Jacob O. Agola, Ph.D. - Publications

Affiliations: 
2011 Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Area:
General Biology, Biochemistry, General Chemistry, Oncology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Guo J, Agola JO, Serda R, Franco S, Lei Q, Wang L, Minster J, Croissant JG, Butler KS, Zhu W, Brinker CJ. Biomimetic Rebuilding of Multifunctional Red Blood Cells: Modular Design Using Functional Components. Acs Nano. PMID 32391687 DOI: 10.1021/Acsnano.9B08714  0.339
2019 Zhu W, Guo J, Amini S, Ju Y, Agola JO, Zimpel A, Shang J, Noureddine A, Caruso F, Wuttke S, Croissant JG, Brinker CJ. SupraCells: Living Mammalian Cells Protected within Functional Modular Nanoparticle-Based Exoskeletons. Advanced Materials (Deerfield Beach, Fla.). e1900545. PMID 31032545 DOI: 10.1002/Adma.201900545  0.302
2019 Zhu W, Guo J, Agola JO, Croissant JG, Wang Z, Shang J, Coker EN, Motevalli B, Zimpel A, Wuttke S, Brinker CJ. Metal-Organic Framework Nanoparticle-Assisted Cryopreservation of Red Blood Cells. Journal of the American Chemical Society. PMID 31017405 DOI: 10.1021/Jacs.9B00992  0.308
2019 Zhu W, Guo J, Ju Y, Serda RE, Croissant JG, Shang J, Coker E, Agola JO, Zhong QZ, Ping Y, Caruso F, Brinker CJ. Modular Metal-Organic Polyhedra Superassembly: From Molecular-Level Design to Targeted Drug Delivery. Advanced Materials (Deerfield Beach, Fla.). e1806774. PMID 30702780 DOI: 10.1002/Adma.201806774  0.348
2019 Noureddine A, Hjelvik EA, Croissant JG, Durfee PN, Agola JO, Brinker CJ. Engineering of large-pore lipid-coated mesoporous silica nanoparticles for dual cargo delivery to cancer cells Journal of Sol-Gel Science and Technology. 89: 78-90. DOI: 10.1007/S10971-018-4772-1  0.303
2016 Durfee PN, Lin YS, Dunphy DR, Muniz AJ, Butler KS, Humphrey KR, Lokke AJ, Agola JO, Chou SS, Chen IM, Wharton W, Townson JL, Willman CL, Brinker CJ. Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells. Acs Nano. PMID 27419663 DOI: 10.1021/Acsnano.6B02819  0.36
2015 Oprea TI, Sklar LA, Agola JO, Guo Y, Silberberg M, Roxby J, Vestling A, Romero E, Surviladze Z, Murray-Krezan C, Waller A, Ursu O, Hudson LG, Wandinger-Ness A. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. Plos One. 10: e0142182. PMID 26558612 DOI: 10.1371/Journal.Pone.0142182  0.586
2015 Hong L, Guo Y, BasuRay S, Agola JO, Romero E, Simpson DS, Schroeder CE, Simons P, Waller A, Garcia M, Carter M, Ursu O, Gouveia K, Golden JE, Aubé J, et al. A Pan-GTPase Inhibitor as a Molecular Probe. Plos One. 10: e0134317. PMID 26247207 DOI: 10.1371/Journal.Pone.0134317  0.63
2015 Agola JO, Sivalingam D, Cimino DF, Simons PC, Buranda T, Sklar LA, Wandinger-Ness A. Quantitative bead-based flow cytometry for assaying Rab7 GTPase interaction with the Rab-interacting lysosomal protein (RILP) effector protein. Methods in Molecular Biology (Clifton, N.J.). 1298: 331-54. PMID 25800855 DOI: 10.1007/978-1-4939-2569-8_28  0.625
2015 Agola JO, Sivalingam D, Cimino DF, Simons PC, Buranda T, Sklar LA, Wandinger-Ness A. Quantitative bead-based flow cytometry for assaying rab7 GTPase interaction with the rab-interacting lysosomal protein (RILP) effector protein Methods in Molecular Biology. 1298: 331-354. DOI: 10.1007/978-1-4939-2569-8_28  0.569
2013 Buranda T, BasuRay S, Swanson S, Agola J, Bondu V, Wandinger-Ness A. Rapid parallel flow cytometry assays of active GTPases using effector beads. Analytical Biochemistry. 442: 149-57. PMID 23928044 DOI: 10.1016/J.Ab.2013.07.039  0.581
2012 Agola JO, Hong L, Surviladze Z, Ursu O, Waller A, Strouse JJ, Simpson DS, Schroeder CE, Oprea TI, Golden JE, Aubé J, Buranda T, Sklar LA, Wandinger-Ness A. A competitive nucleotide binding inhibitor: in vitro characterization of Rab7 GTPase inhibition. Acs Chemical Biology. 7: 1095-108. PMID 22486388 DOI: 10.1021/Cb3001099  0.591
2011 Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clinical Genetics. 80: 305-18. PMID 21651512 DOI: 10.1111/j.1399-0004.2011.01724.x  0.569
2011 Wandinger-Ness A, Kenney SR, Agola J, Roxby J, Surviladze Z, Silberberg M, Zeineldin R, Vestling A, Bologa C, Ursu O, Oprea T, Muller C, Lomo L, Sklar L, Hudson LG. Abstract LB-214: Rac1 and Cdc42 GTPases as novel targets in ovarian cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-214  0.595
Show low-probability matches.